BOFLOX FLAVOUR 20 mg TABLETS FOR DOGS AND CATS

Land: Maleisië

Taal: Engels

Bron: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Werkstoffen:

MARBOFLOXACIN

Beschikbaar vanaf:

My Vet Care Sdn Bhd

INN (Algemene Internationale Benaming):

MARBOFLOXACIN

Eenheden in pakket:

100 Tablets

Geproduceerd door:

Artesan Pharma GmbH & Co. KG

Productkenmerken

COMPOSITION
1 tablet contains: Marbofloxacin, 20 mg.
This
veterinary
medicinal
product
contains
lactose
monohydrate derived from bovine origin.
Round beige cross-snap tablets with brown speckles.
The tablets can be divided into halves or quarters.
INDICATIONS
Treatment of infections caused by strains of microorgan-
isms susceptible to marbofloxacin.
Dogs: Skin and soft tissue infections (skinfold pyoder-
ma, impetigo, folliculitis, furunculosis, cellulitis), urinary
tract infections (UTI) associated or not with prostatitis or
epididymitis and respiratory tract infections.
Cats: Skin and soft tissue infections (wounds, abscesses,
phlegmons) and upper respiratory tract infections.
CONTRAINDICATIONS
Marbofloxacin should not be used in dogs aged less
than 12 months, or less than 18 months for exception-
ally large breeds of dogs, such as Great Danes, Briard,
Bernese, Bouvier and Mastiffs, with a longer growth
period. Do not use in cats aged less than 16 weeks. Do
not use in cases of hypersensitivity to fluoroquinolones
or any of the excipients of the product. Do not use in
cases of resistance against quinolones, since (almost)
complete cross-resistance exists against and other
fluoroquinolones. Not suitable for infections resulting
from strict anaerobes, yeast or fungi.
ADVERSE REACTIONS
At the therapeutic recommended dosage, no severe
side effects are to be expected in dogs and cats. In
particular, no lesions of the articular joints were en-
countered
in
clinical
studies
at
the
recommended
dose rate. However, joint pain and/or neurological
symptoms
(ataxia,
aggressiveness,
convulsion,
de-
pression) may occur on rare occasions. Allergic reac-
tions have been observed (temporary skin reactions)
due to the histamine release that may occur. Mild side
effects such as vomiting, softening of faeces, modifi-
cation of thirst or transient increase in activity may
occasionally occur. These signs cease spontaneously
after treatment and do not necessitate cessation of
treatment.
The frequency of adverse reactions is defined usi